Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen global Patient Access — Free Medicines Donated in Low- & Middle-Income Countries (LMICs) ($M) ($M)
Amgen Sustainability Highlights Report
Latest, FY2025
51
Period ended Dec 31, 2025
Change on a year earlier
-77.2%
224 in FY2024
History
5 years
Since FY2021
Sources
1
Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Global Patient Access — Free Medicines Donated in Low- & Middle-Income Countries (LMICs) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51 | -77.2% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2024 | Dec 31, 2024 | 224 | +100.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2023 | Dec 31, 2023 | 112 | +23.1% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2022 | Dec 31, 2022 | 91 | +1,720.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2021 | Dec 31, 2021 | 5 | – | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
Breakdown
What makes up global patient access — free medicines donated in low- & middle-income countries (lmics) ($m)
Cite this data
StockData. (2026). Amgen Global Patient Access — Free Medicines Donated in Low- & Middle-Income Countries (LMICs) ($M) ($M), annual FY2021–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/esg_lmic_val
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.